NDC 51759-202

AJOVY

Fremanezumab-vfrm

AJOVY is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Fremanezumab.

• Product ID: 51759-202_08ae1956-25f5-4553-be30-333c558fd801
• NDC: 51759-202
• Product Type: Human Prescription Drug
• Proprietary Name: AJOVY
• Generic Name: Fremanezumab-vfrm
• Dosage Form: Injection
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2020-03-29
• Marketing Category: BLA / BLA
• Application Number: BLA761089
• Labeler Name: Teva Pharmaceuticals USA, Inc.
• Substance Name: FREMANEZUMAB
• Active Ingredient Strength: 225 mg/1.5mL
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 51759-202-10

1 CONTAINER in 1 CARTON (51759-202-10) > 1.5 mL in 1 CONTAINER

• Marketing Start Date: 2020-03-29
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51759-202-11 [51759020211]

AJOVY INJECTION

• Marketing Category: BLA
• Application Number: BLA761089
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2020-03-29

NDC 51759-202-10 [51759020210]

AJOVY INJECTION

• Marketing Category: BLA
• Application Number: BLA761089
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2020-03-29

Drug Details

Active Ingredients

Ingredient	Strength
FREMANEZUMAB	225 mg/1.5mL

NDC Crossover Matching brand name "AJOVY" or generic name "Fremanezumab-vfrm"

NDC	Brand Name	Generic Name
51759-202	AJOVY	fremanezumab-vfrm
51759-204	AJOVY	fremanezumab-vfrm